We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cardiodiabetology: newer pharmacologic strategies for reducing cardiovascular disease risks.
- Authors
Wong, Nathan D.
- Abstract
The article discusses that cardiovascular diseases (CVD) can be prevented by optimization of associated risk factors. Besides lifestyle management, newer and existing pharmacologic approaches are available, particularly for the management of lipids, blood pressure, and blood glucose. For higher-risk patients, antiplatelet therapy is recommended. Newer medications for diabetes, including sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists, reduce CVD.
- Publication
Canadian Journal of Physiology & Pharmacology, 2022, Vol 100, Issue 10, p956
- ISSN
0008-4212
- Publication type
Article
- DOI
10.1139/cjpp-2022-0065